HOW TO MAKE MONEY: Inovio Pharmaceuticals Inc. (NASDAQ; INO) Inovio Pharmaceuticals Inc. rallied more than 69% Tuesday, after the company said it’s accelerating the timeline for development of a vaccine to treat the coronavirus COVID-19 and expects to start human trials in the U.S. next month.
The stock INO, +69.70% has more than doubled in three months as expectations for the company’s vaccine, called INO-4800, have grown, and as the virus has spread to more than 91,000 people and caused more than 3,100 deaths.
Plymouth Meeting, Pennsylvania-based Inovio specializes in developing DNA vaccines and has created products to treat 15 indications. It is the only company to have a phase 2 vaccine for the coronavirus that caused Middle East respiratory syndrome, or MERS. The company was called on to help during the 2016 Zika outbreak and the Ebola outbreak in 2014.
Join The RICH TV LIVE CHANNEL MEMBERSHIP -
JOIN TRADING ACADEMY HERE -
Subscribe -
Visit - & www.richpicksdaily.com a community for stocks, news, and trending topics. #RICHTVLIVE #COVID19 #INOVIO
Popular Uploads -
Most Recent Upload -
YouTube Channel Page -
Subscribe -
Rich TV Live Playlist -
RICH TV LIVE TOP 10 STOCKS Playlist -
Disclaimer
RICH TV LIVE INC. company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RICH TV LIVE reports company profiles or other investor relations materials and presentations are subject to change. RICH TV LIVE and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
Investing is inherently risky. RICH TV LIVE is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. Disclosure -
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov/Canadian CSA
0 Comments